MDM2 counteracts resistance to CDK4/6 inhibitors for melanoma therapy by Staff August 15, 2019 August 15, 2019 7 views 7A study has identified a possible second-line treatment for melanoma patients.Source: sciencedaily.com ScienceDaily 0 FacebookTwitterPinterestEmail previous post Drug interaction research: Evolution clues next post You Can Now Make Your Own Instagram AR Effects Related Posts Early trauma cuts life short for squirrels, and... April 25, 2024 Food in sight? The liver is ready! April 25, 2024 Climate change could become the main driver of... April 25, 2024 Advance in the treatment of acute heart failure... April 25, 2024 RNA modification is responsible for the disruption of... April 25, 2024 Voluntary corporate emissions targets not enough to create... April 25, 2024